PorA Variable Antigenic Regions VR1, VR2, and VR3 of Neisseria meningitidis Serogroups B and C Isolated in Brazil from 1999 to 2004
- 1 July 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (7) , 3683-3685
- https://doi.org/10.1128/iai.01721-06
Abstract
The high genetic diversity found among the PorA regions VR1 and VR2 of 101 Neisseria meningitidis isolates from patients with meningococcal disease and healthy carriers in Brazil contrasts with the stability found in the PorA VR3 of these isolates. The presence of VR3 epitope variant 35 or 36 on the surfaces of 87% of the strains analyzed suggests that these antigens should be considered for inclusion in new formulations of vaccines against serogroup B meningococci in Brazil.Keywords
This publication has 24 references indexed in Scilit:
- Comparison and Correlation of Neisseria meningitidis Serogroup B Immunologic Assay Results and Human Antibody Responses following Three Doses of the Norwegian Meningococcal Outer Membrane Vesicle Vaccine MenBvacInfection and Immunity, 2006
- Multilocus sequence typing and repetitive element-based polymerase chain reaction analysis of Neisseria meningitidis isolates in Brazil reveal the emergence of 11 new sequence types genetically related to the ST-32 and ST-41/44 complexes and high prevalence of strains related to hypervirulent lineagesDiagnostic Microbiology and Infectious Disease, 2005
- Crystal Structure of an Anti-meningococcal Subtype P1.4 PorA Antibody Provides Basis for Peptide–Vaccine DesignJournal of Molecular Biology, 2005
- MeNZB™: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strainVaccine, 2005
- Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?Vaccine, 2003
- Semiautomation of Multilocus Sequence Typing for the Characterization of Clinical Isolates of Neisseria meningitidisJournal of Clinical Microbiology, 2001
- Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic casesNoteAPMIS, 2000
- Sequencing ofporAfrom clinical isolates ofNeisseria meningitidisdefines a subtyping scheme and its genetic regulationCanadian Journal of Microbiology, 1998
- Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, ChileVaccine, 1995
- Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptideJournal of General Microbiology, 1993